Liberty Wealth Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-979
Closed -$121K 726
2021
Q3
$121K Buy
979
+338
+53% +$43.7K 0.04% 250
2021
Q2
$80K Sell
641
-583
-48% -$73.2K 0.03% 244
2021
Q1
$136K Hold
1,224
0.07% 144
2020
Q4
$136K Buy
1,224
+94
+8% +$10.3K 0.07% 143
2020
Q3
$117K Sell
1,130
-21
-2% -$2.11K 0.07% 147
2020
Q2
$106K Sell
1,151
-41
-3% -$3.93K 0.07% 143
2020
Q1
$108K Sell
1,192
-8
-0.7% -$851 0.09% 130
2019
Q4
$136K Buy
1,200
+13
+1% +$1.43K 0.11% 127
2019
Q3
$129K Buy
1,187
+103
+10% +$10.7K 0.12% 125
2019
Q2
$106K Sell
1,084
-2
-0.2% -$183 0.09% 158
2019
Q1
$98K Buy
1,086
+46
+4% +$4.12K 0.07% 140
2018
Q4
$94K Buy
+1,040
New +$97.2K 0.07% 135

Other funds holding MDT

Liberty Wealth Management's MDT Position: Q4 2021 in Review

Liberty Wealth Management sold out of Medtronic (MDT) in Q4 2021, closing a stake of 979 shares — an estimated $121K sold.

Liberty Wealth Management first reported a position in MDT in Q4 2018 and held it in 12 quarters. The position peaked at $136K in Q1 2021. 2,059 funds tracked by Wall St. Rank hold MDT as of Q4 2021.

  • Liberty Wealth Management reported no remaining Medtronic position as of Q4 2021 after selling out during the quarter.
  • Liberty Wealth Management sold 979 Medtronic shares in Q4 2021, an estimated $121K.
  • Liberty Wealth Management first reported a position in Medtronic in Q4 2018 and held it in 12 quarters.
  • Liberty Wealth Management's Medtronic position peaked at $136K in Q1 2021.
  • 2,059 funds tracked by Wall St. Rank held Medtronic as of Q4 2021.

Based on Liberty Wealth Management's 13F filing for Q4 2021, filed 15 Feb 2022.